Literature DB >> 20562611

The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing.

Simon D McLaughlin1, Alan W Walker, Carol Churcher, Susan K Clark, Paris P Tekkis, Matthew W Johnson, Julian Parkhill, Paul J Ciclitira, Gordon Dougan, Ralph John Nicholls, Liljana Petrovska.   

Abstract

OBJECTIVE: To identify, compare, and contrast the microbiota in patients with and without pouchitis after restorative proctocolectomy (RPC) for ulcerative colitis (UC) and familial adenomatous polyposis (FAP). SUMMARY BACKGROUND DATA: Pouchitis is the most common complication following RPC. An abnormal host-microbial interaction has been implicated. We investigated the pouch microbiota in patients with and without pouchitis undergoing restorative proctocolectomy for UC and FAP.
METHODS: Mucosal pouch biopsies, taken from 16 UC (pouchitis 8) and 8 FAP (pouchitis 3) patients were analyzed to the species (or phylotype) level by cloning and sequencing of 3184 full-length bacterial 16S rRNA genes.
RESULTS: There was a significant increase in Proteobacteria (P = 0.019) and a significant decrease in Bacteroidetes (P = 0.001) and Faecalibacterium prausnitzii (P = 0.029) in the total UC compared with the total FAP cohort, but only limited differences were found between the UC nonpouchitis and pouchitis groups and the FAP pouchitis and nonpouchitis groups. Bacterial diversity in the FAP nonpouchitis group was significantly greater than in UC nonpouchitis (P = 0.019) and significantly greater in UC nonpouchitis compared with UC pouchitis (P = 0.009). No individual species or phylotype specifically associated with either UC or FAP pouchitis was found.
CONCLUSIONS: UC pouch patients have a different, less diverse, gut microbiota than FAP patients. A further reduction in bacterial diversity but no significant dysbiosis occurs in those with pouchitis. The study suggests that a dysbiosis occurs in the ileal pouch of UC RPC patients which predisposes to, but may not directly cause, pouchitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562611      PMCID: PMC3292798          DOI: 10.1097/SLA.0b013e3181e3dc8b

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  52 in total

Review 1.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

Review 2.  Probiotics and inflammatory bowel diseases.

Authors:  M Schultz; R B Sartor
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness.

Authors:  Patrick D Schloss; Jo Handelsman
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

4.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.

Authors:  B Kleessen; A J Kroesen; H J Buhr; M Blaut
Journal:  Scand J Gastroenterol       Date:  2002-09       Impact factor: 2.423

Review 6.  Diagnosis and treatment of patients with pouchitis.

Authors:  Bo Shen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.

Authors:  T Mimura; F Rizzello; U Helwig; G Poggioli; S Schreiber; I C Talbot; R J Nicholls; P Gionchetti; M Campieri; M A Kamm
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces.

Authors:  Erwin G Zoetendal; Atte von Wright; Terttu Vilpponen-Salmela; Kaouther Ben-Amor; Antoon D L Akkermans; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

10.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.

Authors:  P Seksik; L Rigottier-Gois; G Gramet; M Sutren; P Pochart; P Marteau; R Jian; J Doré
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  38 in total

Review 1.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  The bacterial pathogenesis and treatment of pouchitis.

Authors:  S D McLaughlin; S K Clark; P P Tekkis; R J Nicholls; P J Ciclitira
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 3.  Diagnosis and management of pouchitis and ileoanal pouch dysfunction.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Curr Gastroenterol Rep       Date:  2010-12

Review 4.  Probiotics for the treatment of inflammatory bowel disease.

Authors:  Ganesh R Veerappan; John Betteridge; Patrick E Young
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 5.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

Review 6.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

7.  Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype.

Authors:  Andrea D Tyler; Richard Kirsch; Raquel Milgrom; Joanne M Stempak; Boyko Kabakchiev; Mark S Silverberg
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

8.  Update on the pathogenesis and management of pouchitis.

Authors:  Saleem Chowdhry; Jeffry A Katz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

9.  Chronic use of PPI and H2 antagonists decreases the risk of pouchitis after IPAA for ulcerative colitis.

Authors:  Lisa S Poritz; Rishabh Sehgal; Arthur S Berg; Lacee Laufenberg; Christine Choi; Emmanuelle D Williams
Journal:  J Gastrointest Surg       Date:  2013-03-27       Impact factor: 3.452

Review 10.  The gut microbiota in IBD.

Authors:  Chaysavanh Manichanh; Natalia Borruel; Francesc Casellas; Francisco Guarner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.